178 related articles for article (PubMed ID: 28567714)
1. Epidemiology of hip fracture and the development of FRAX in Ukraine.
Povoroznyuk VV; Grygorieva NV; Kanis JA; Ev M; Johansson H; Harvey NC; Korzh MO; Strafun SS; Vaida VM; Klymovytsky FV; Vlasenko RO; Forosenko VS
Arch Osteoporos; 2017 Dec; 12(1):53. PubMed ID: 28567714
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of osteoporotic fracture in Moldova and development of a country-specific FRAX model.
Zakroyeva A; Lesnyak O; Cazac V; Groppa L; Russu E; Chislari L; Rotaru L; Johansson H; Harvey NC; McCloskey E; Lorentzon M; Kanis JA
Arch Osteoporos; 2020 Jan; 15(1):13. PubMed ID: 31993755
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models.
Ramanau H; Chernyanin I; Rudenka E; Lesnyak O; Zakroyeva A; Bilezikian JP; Johansson H; Harvey NC; McCloskey EV; Kanis JA
Arch Osteoporos; 2018 Apr; 13(1):42. PubMed ID: 29666948
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model.
Issayeva S; Lesnyak O; Zakroyeva A; Issayeva B; Dilmanova D; Johansson H; Liu E; Lorentzon M; Harvey NC; McCloskey E; Kanis JA
Arch Osteoporos; 2020 Feb; 15(1):30. PubMed ID: 32108270
[TBL] [Abstract][Full Text] [Related]
5. The effects of a FRAX revision for the USA.
Kanis JA; Johansson H; Oden A; Dawson-Hughes B; Melton LJ; McCloskey EV
Osteoporos Int; 2010 Jan; 21(1):35-40. PubMed ID: 19705047
[TBL] [Abstract][Full Text] [Related]
6. Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study.
Ettinger B; Ensrud KE; Blackwell T; Curtis JR; Lapidus JA; Orwoll ES;
Osteoporos Int; 2013 Apr; 24(4):1185-93. PubMed ID: 23179575
[TBL] [Abstract][Full Text] [Related]
7. Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures.
Lalmohamed A; Welsing PM; Lems WF; Jacobs JW; Kanis JA; Johansson H; De Boer A; De Vries F
Osteoporos Int; 2012 Mar; 23(3):861-9. PubMed ID: 22120910
[TBL] [Abstract][Full Text] [Related]
8. Incidence of hip fracture in Brazil and the development of a FRAX model.
Zerbini CA; Szejnfeld VL; Abergaria BH; McCloskey EV; Johansson H; Kanis JA
Arch Osteoporos; 2015; 10():224. PubMed ID: 26303038
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of hip fractures in Bulgaria: development of a country-specific FRAX model.
Kirilova E; Johansson H; Kirilov N; Vladeva S; Petranova T; Kolarov Z; Liu E; Lorentzon M; Vandenput L; Harvey NC; McCloskey E; Kanis JA
Arch Osteoporos; 2020 Feb; 15(1):28. PubMed ID: 32108268
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of fractures in Armenia: development of a country-specific FRAX model and comparison to its surrogate.
Lesnyak O; Sahakyan S; Zakroyeva A; Bilezikian JP; Hutchings N; Babalyan V; Galstyan R; Lebedev A; Johansson H; Harvey NC; McCloskey E; Kanis JA
Arch Osteoporos; 2017 Nov; 12(1):98. PubMed ID: 29116417
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of hip fracture in Qatar and development of a country specific FRAX model.
Abdulla N; Alsaed OS; Lutf A; Alam F; Abdulmomen I; Al Emadi S; Harvey NC; Liu E; Vandenput L; Lorentzon M; McCloskey E; Kanis JA; Johansson H
Arch Osteoporos; 2022 Mar; 17(1):49. PubMed ID: 35303174
[TBL] [Abstract][Full Text] [Related]
12. FRAX® probabilities and risk of major osteoporotic fracture in France.
Couris CM; Chapurlat RD; Kanis JA; Johansson H; Burlet N; Delmas PD; Schott AM
Osteoporos Int; 2012 Sep; 23(9):2321-7. PubMed ID: 22179418
[TBL] [Abstract][Full Text] [Related]
13. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.
Leslie WD; Lix LM; Langsetmo L; Berger C; Goltzman D; Hanley DA; Adachi JD; Johansson H; Oden A; McCloskey E; Kanis JA
Osteoporos Int; 2011 Mar; 22(3):817-27. PubMed ID: 21161509
[TBL] [Abstract][Full Text] [Related]
14. Assessing the risk of osteoporotic fractures: the Ecuadorian FRAX model.
Lopez Gavilanez E; Johansson H; McCloskey E; Harvey NC; Segale Bajana A; Marriott Blum D; Navarro Grijalva M; Diaz Curiel M; Kanis JA
Arch Osteoporos; 2019 Aug; 14(1):93. PubMed ID: 31440846
[TBL] [Abstract][Full Text] [Related]
15. A surrogate FRAX model for Pakistan.
Naureen G; Johansson H; Iqbal R; Jafri L; Khan AH; Umer M; Liu E; Vandenput L; Lorentzon M; Harvey NC; McCloskey EV; Kanis JA
Arch Osteoporos; 2021 Feb; 16(1):34. PubMed ID: 33595723
[TBL] [Abstract][Full Text] [Related]
16. FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
Leslie WD; Majumdar SR; Morin SN; Lix LM; Johansson H; Oden A; McCloskey EV; Kanis JA
Osteoporos Int; 2017 Sep; 28(9):2557-2564. PubMed ID: 28593449
[TBL] [Abstract][Full Text] [Related]
17. A surrogate FRAX model for the Kyrgyz Republic.
Lesnyak O; Zakroyeva A; Lobanchenko O; Johansson H; Liu E; Lorentzon M; Harvey NC; McCloskey E; Kanis JA
Arch Osteoporos; 2020 May; 15(1):68. PubMed ID: 32377964
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men.
Yu R; Leung J; Woo J
J Am Med Dir Assoc; 2014 Dec; 15(12):918-23. PubMed ID: 25262197
[TBL] [Abstract][Full Text] [Related]
19. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
[TBL] [Abstract][Full Text] [Related]
20. Updated fracture incidence rates for the Italian version of FRAX®.
Piscitelli P; Chitano G; Johannson H; Brandi ML; Kanis JA; Black DM
Osteoporos Int; 2013 Mar; 24(3):859-66. PubMed ID: 22638710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
